glp 1 medicines GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Antiinflammatory actions of GLP-1 medicines

GLP-1s often work better for both goals

Food and Drug Administration (FDA) on the 1st approved 'Foundayo (ingredient name: orforglipron),' an oral obesity treatment developed by Eli Lilly, the company that supplies the obesity drug 'Mounjaro.' This is the second oral GLP-1 class obesity treatment to be approved, following the pill form of Novo Nordisk's 'Wegovy' last December

Its a hormone your body naturally produces in the gut after you eat

BMJ 2021;372:n71

15 likewise, lixisenatide was withdrawn from the US market as of January 1, 2023, for commercial reasons, rather than because of any safety or efficacy issues

Metabolic benefits, such as weight loss and low-density lipoprotein (LDL) reduction, were also observed, with good tolerability [17]